Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Trilaurin (Glycerol Tridodecanoate): Lab Handling and Applic

    2026-07-05

    Trilaurin (Glycerol Tridodecanoate): Lab Handling and Application Guide

    What This Product Solves

    Trilaurin, also known as glycerol tridodecanoate, addresses key formulation and synthesis challenges in pharmaceutical, biochemical, and nanotechnology workflows. As a long-chain triacylglycerol C12, it acts as a lipid excipient for solid lipid microparticles (SLM) and lipid nanoparticles (LNP), enabling the oral delivery of peptide and protein drugs by enhancing their stability against enzymatic degradation. In biocatalytic synthesis, trilaurin serves as a triacylglycerol substrate for enzymatic production of fatty amines under mild conditions. Its solid-state properties and high hydrophobicity make it suitable for constructing colloidal drug carriers and for use as a control substance in dermatological and immunological models, but preclude its use in aqueous systems without proper solubilization strategies. For detailed background on laboratory use, see Trilaurin (Glycerol Tridodecanoate): Protocols and Lab Use.

    Protocol Parameters

    • Solubility in DMSO: 2.37 mg/mL (with gentle warming and ultrasonic treatment) | Use for preparing stock solutions in biochemical and pharmaceutical assays requiring organic solvents | Ensures complete dissolution and reproducibility in workflows requiring precise lipid dosing | Product information
    • Solubility in Ethanol: 24.45 mg/mL | Suitable for high-concentration preparations or where ethanol is the preferred solvent | Enables efficient formulation of LNPs or SLMs at scale | Product information
    • Storage Temperature: -20°C (solid form) | Long-term stability and prevention of degradation; solutions should be used short-term only | Aligns with best practices for lipid excipient storage and minimizes risk of hydrolysis | Product information
    • Biocatalytic Synthesis Substrate Concentration: 2 mM (workflow recommendation) | Optimized for enzymatic production of fatty amines (e.g., laurylamine) with lipase catalysts at 30°C over 20 hours | Achieves high conversion rates and selectivity without excess substrate | Workflow recommendation
    • Cosmetic Application Range: 0.2%–46% (w/w) | Used as a skin conditioning and thickening agent | Provides viscosity and emollient properties in topical formulations | Product information

    Workflow Setup and QC Checklist

    • Confirm trilaurin lot identity and purity before use; reference batch COA as supplied by APExBIO or equivalent vendor documentation.
    • For solid lipid microparticle or nanoparticle preparation, weigh trilaurin using a calibrated analytical balance and dissolve in ethanol (for high loads) or DMSO (for lower concentration needs) as dictated by the solubility profile. Apply gentle warming and sonication to expedite dissolution.
    • If used as a biocatalytic substrate, pre-dissolve trilaurin at the recommended concentration (e.g., 2 mM) in the chosen organic solvent, ensuring complete solubilization to prevent substrate precipitation during enzymatic reactions. Reference protocol details from Direct Biocatalytic Synthesis of Fatty Amines from Trilaurin for enzymatic workflows.
    • For oral drug delivery research, incorporate trilaurin into LNP or SLM formulations according to established lipid ratios and fabrication methods; maintain all lipid solutions chilled and protected from light to prevent oxidation.
    • Store solid trilaurin at -20°C in airtight, light-protected containers; do not refreeze thawed solutions. Use freshly prepared solutions within the shortest feasible timeframe to avoid hydrolysis or oxidation.
    • Document all protocol modifications and include solvent lot numbers, preparation temperatures, and handling time to support reproducibility and troubleshooting.

    Common Failure Modes and Fixes

    • Incomplete Dissolution: If visible particulates remain after standard warming and sonication, confirm solvent volume and temperature. Incrementally increase temperature (not exceeding lipid degradation thresholds) and extend sonication time. Avoid water as a primary solvent due to insolubility.
    • Precipitation in Reaction Mix: Verify that the substrate concentration does not exceed the solubility limit in the working solvent. Dilute as needed or switch to ethanol for higher concentrations. Ensure all components are equilibrated to the same temperature before mixing.
    • Degradation or Hydrolysis: If lipid breakdown is detected (e.g., by TLC or HPLC), check that trilaurin has been continuously stored at -20°C and that freeze–thaw cycles are minimized. Prepare solutions immediately prior to use to reduce exposure to moisture and ambient temperatures.
    • Batch-to-Batch Variability: Always reference the certificate of analysis for each lot, and, when possible, perform a small-scale pilot formulation before full-scale batches to identify any solubility or performance deviations.

    Scope and Limitations

    Trilaurin is highly effective as a lipid excipient for solid lipid microparticles and as a substrate in biocatalytic synthesis, but its hydrophobicity precludes direct use in aqueous workflows. It is not an effective adjuvant in skin sensitization models compared to shorter-chain analogs, as demonstrated by comparative studies (Trilaurin Fails as an Adjuvant in Mouse Skin Sensitization Models). When used in oral delivery of peptide and protein drugs, trilaurin can enhance bioavailability by protecting actives from proteolytic enzymes, but formulation must be tailored to drug physicochemical compatibility and target tissue. In cosmetic applications, its concentration should be controlled to maintain desired viscosity and skin feel. For nanoparticle- or microgel-based delivery systems in oncology, trilaurin provides matrix structure and payload protection but should be selected based on compatibility with other lipids and payload molecules. Direct application to aqueous or highly polar systems is not recommended without a suitable co-solvent or emulsification strategy.

    Conclusion

    Trilaurin (glycerol tridodecanoate) is a versatile tool for research involving lipid-based delivery systems, biocatalytic synthesis, and formulation science, provided its solubility and storage constraints are respected. For protocol specifics and product characteristics, consult the Trilaurin product page. Consistent handling, solvent selection, and quality control are essential for reproducible results in both small- and large-scale laboratory applications.